Patent · US Active

Methods of antagonizing signal transduction in dorsal root ganglion cells

US8637015B2 · kind B2 · utility

22Cited by
26References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 23, 2013
Grant dateJan 28, 2014
Priority date—
Expiry dateJan 23, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Use of antagonists to IL-31 are used to treat inflammation and pain by inhibiting, preventing, reducing, minimizing, limiting or minimizing stimulation in neuronal tissues. Such antagonists include antibodies and fragments, derivative, or variants thereof. Symptoms such as pain, tingle, sensitization, tickle associated with neuropathies are ameliorated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.